Treatment of autoimmunity and transplant rejection through establishment and/or promotion of tolerogenic processes by fibroblast-mediated reprogramming of antigen …
T Ichim - US Patent App. 17/754,809, 2023 - Google Patents
US20230149523A1 - Treatment of autoimmunity and transplant rejection through
establishment and/or promotion of tolerogenic processes by fibroblast-mediated …
establishment and/or promotion of tolerogenic processes by fibroblast-mediated …
Inducible pluripotent stem cell derived regenerative t cells
T Ichim, A Patel, C Bartlett - US Patent App. 18/331,098, 2023 - Google Patents
US20230407254A1 - Inducible pluripotent stem cell derived regenerative t cells - Google
Patents US20230407254A1 - Inducible pluripotent stem cell derived regenerative t cells …
Patents US20230407254A1 - Inducible pluripotent stem cell derived regenerative t cells …
Calcineurin inhibitor resistant immune cells for use in adoptive cell transfer therapy
L Jeker, M Dölz - US Patent App. 17/426,385, 2022 - Google Patents
QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C [C@@
H](O)[C@ H](OC) C [C@@ H] 1\C= C (/C)[C@@ H] 1 [C@ H](C)[C@@ H](O) CC (= O)[C …
H](O)[C@ H](OC) C [C@@ H] 1\C= C (/C)[C@@ H] 1 [C@ H](C)[C@@ H](O) CC (= O)[C …
Genetically modified immune cells expressing a chimeric antigen receptor and having reduced proinflammatory cytokine signaling
HU Biliang - US Patent App. 17/995,577, 2023 - Google Patents
US20230149465A1 - Genetically modified immune cells expressing a chimeric antigen
receptor and having reduced proinflammatory cytokine signaling - Google Patents …
receptor and having reduced proinflammatory cytokine signaling - Google Patents …
Methods to improve cell therapy
R Sackstein - 2016 - Google Patents
WO2016109543A1 - Methods to improve cell therapy - Google Patents WO2016109543A1 -
Methods to improve cell therapy - Google Patents Methods to improve cell therapy Download …
Methods to improve cell therapy - Google Patents Methods to improve cell therapy Download …
Bi-specific chimeric antigen receptor t cells targeting cd83 and interleukin 6 receptor
B Betts, M Davila - US Patent App. 17/759,271, 2023 - Google Patents
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC [C@@ H]
1NC (= O)[C@ H]([C@ H](O)[C@ H](C) C\C= C\C) N (C) C (= O)[C@ H](C (C) C) N (C) C …
1NC (= O)[C@ H]([C@ H](O)[C@ H](C) C\C= C\C) N (C) C (= O)[C@ H](C (C) C) N (C) C …
processo para gerar composições terapêuticas de células modificadas
N Yee, P BEAUCHESNE, ML Bonyhadi, RL Crisman… - 2020 - Google Patents
BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis (4-chlorophenyl) methyl]-4-N-[3-[bis (4-
chlorophenyl) methyl]-4-(dimethylamino) phenyl]-1-N, 1-N-dimethylbenzene-1, 4-diamine …
chlorophenyl) methyl]-4-(dimethylamino) phenyl]-1-N, 1-N-dimethylbenzene-1, 4-diamine …
Immunotherapy using stem cells
AT Harrelson, M Kaufmann - US Patent App. 14/957,004, 2016 - Google Patents
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]
amino]-4-methyl-1-oxopentan-2-yl] amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl] …
amino]-4-methyl-1-oxopentan-2-yl] amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl] …
Generation of t-cells by direct reprogramming from fibroblasts and msc
CFRL Pereira, M Pulé - US Patent App. 18/279,568, 2024 - Google Patents
US20240166996A1 - Generation of t-cells by direct reprogramming from fibroblasts and msc -
Google Patents US20240166996A1 - Generation of t-cells by direct reprogramming from …
Google Patents US20240166996A1 - Generation of t-cells by direct reprogramming from …
Modified cytotoxic t cells and methods of use thereof
S Anish - 2021 - Google Patents
WO2021081232A1 - Modified cytotoxic t cells and methods of use thereof - Google Patents
WO2021081232A1 - Modified cytotoxic t cells and methods of use thereof - Google Patents …
WO2021081232A1 - Modified cytotoxic t cells and methods of use thereof - Google Patents …